A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS
Publication
, Conference
Desjardins, A; Vredenburgh, JJ; Gururangan, S; Peters, KB; Friedman, AH; Friedman, H; Reardon, DA
Published in: NEURO-ONCOLOGY
2009
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
2009
Volume
11
Issue
5
Start / End Page
633 / 633
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Vredenburgh, J. J., Gururangan, S., Peters, K. B., Friedman, A. H., Friedman, H., & Reardon, D. A. (2009). A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. In NEURO-ONCOLOGY (Vol. 11, pp. 633–633).
Desjardins, Annick, James J. Vredenburgh, Sridharan Gururangan, Katherine B. Peters, Allan H. Friedman, Henry Friedman, and David A. Reardon. “A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS.” In NEURO-ONCOLOGY, 11:633–633, 2009.
Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Friedman AH, Friedman H, et al. A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. In: NEURO-ONCOLOGY. 2009. p. 633–633.
Desjardins, Annick, et al. “A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS.” NEURO-ONCOLOGY, vol. 11, no. 5, 2009, pp. 633–633.
Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Friedman AH, Friedman H, Reardon DA. A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. NEURO-ONCOLOGY. 2009. p. 633–633.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
2009
Volume
11
Issue
5
Start / End Page
633 / 633
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences